Advertisement
Advertisement
VRDN
Viridian Therapeutics, Inc. Common Stock
22.00
USDSponsored
-0.88
-3.85%
Aug 13, 15:47 UTC -4
Open
Viridian Therapeutics, Inc. Common Stock Profile
About
Info & Links
CEO
Stephen Mahoney
Headquarters
WALTHAM, MA 02453, UNITED STATES
Industry
Sector
Website
Auditor
KPMG LLP
Share holders
9
Employees
252
Viridian Therapeutics, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
2.49B
Enterprise Value
2.57B
Enterprise Value/EBITDA(ttm)
-6.25
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
36.59
Price to Book(mrq)
4.70
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
100.00%
Operating Margin(ttm)
-505.86%
Profit Margin(ttm)
-74984.67%
Return on Equity(ttm)
-76.65%
Return on Invested Capital(ttm)
-56.57%
Return on Assets(ttm)
-47.64%
Income Statement
Revenue(ttm)
71.13M
Revenue Per Share(ttm)
0.63
Gross Profit(ttm)
71.13M
EBITDA(ttm)3
-410.93M
Net Income Available to Common(ttm)
-386.97M
Diluted EPS(ttm)
-3.37
Share Statistics
Beta (5Y Monthly)
0.91
52-Week Change
22.43%
S&P 500 52-Week Change
20.68%
S&P 500 Member
No
Stock Optionable
Yes
Total Shares Outstanding1
113.29M
Dividend Yield
0.00%
Float4
110.57M
% Held by Insiders
2.40%
% Held by Institutions
--
Balance Sheet
Total Cash(mrq)
981.53M
Total Cash Per Share(mrq)
8.66
Total Debt(mrq)
242.16M
Total Debt/Equity(mrq)
7.93%
Current Ratio(mrq)
15.15%
Quick Ratio(mrq)
15.15%
Book Value Per Share(mrq)
6.21
Cash Flow
Operating Cash Flow Per Share(ytd)
-1.17
Free Cash Flow(ytd)
-119.68M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement